Product Program year 2025 Source: CMS Open Payments

Envista Envy Iol

Device Ophthalmology

PDI 10757770637529

Open in the dashboard

General payments

$283,164

1,732 payments

Research payments

$0

0 payments

Through program year 2025, $283,164 in general payments and $0 in research payments were reported against Envista Envy Iol (Ophthalmology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $283,051 1,731
2024 General $113 1

Breakdown

Who paid General payments · program years 2024–2025
  1. Bausch & Lomb Americas Inc. $283,164 1,732 payments
Top recipients General payments · program year 2025
  1. Alice Epitropoulos Ophthalmology · Columbus, OH $23,272 8% · 9 payments
  2. Iqbal Ahmed Ophthalmology · Salt Lake City, UT $23,013 8% · 1 payment
  3. Brett Bielory Ophthalmology · Rutherford, NJ $18,834 7% · 6 payments
  4. Kenneth Beckman Ophthalmology · Westerville, OH $10,399 4% · 8 payments
  5. Mitchell Shultz Ophthalmology · Northridge, CA $10,337 4% · 10 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Ophthalmology $254,884 94% · 779 practitioners
  2. Optometrist $4,821 2% · 157 practitioners
  3. Cornea and External Diseases Specialist Ophthalmology $2,974 1% · 20 practitioners
  4. Glaucoma Specialist Ophthalmology $1,837 <1% · 24 practitioners
  5. Retina Specialist Ophthalmology $1,297 <1% · 14 practitioners

The top 5 of 32 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $46,482 16% · 85 recipients
  2. Ohio $38,791 14% · 15 recipients
  3. California $34,334 12% · 170 recipients
  4. Utah $26,648 9% · 8 recipients
  5. New Jersey $23,583 8% · 33 recipients

The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,732 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record